Two-Drug Injection Suppresses HIV As Well As Three-Drug Combo, Clinical Trial Indicates.
August 16, 2018
Reuters (8/15, Hirschler) reports GlaxoSmithKline’s ViiV Healthcare unit announced Wednesday that its “experimental two-drug injection of cabotegravir and rilpivirine maintained similar rates” of HIV viral suppression “compared with a standard three-drug...